283 related articles for article (PubMed ID: 11393291)
1. Immunolocalisation of Burkholderia cepacia in the lungs of cystic fibrosis patients.
Sajjan U; Corey M; Humar A; Tullis E; Cutz E; Ackerley C; Forstner J
J Med Microbiol; 2001 Jun; 50(6):535-546. PubMed ID: 11393291
[TBL] [Abstract][Full Text] [Related]
2. Preferential adherence of cable-piliated burkholderia cepacia to respiratory epithelia of CF knockout mice and human cystic fibrosis lung explants.
Sajjan U; Wu Y; Kent G; Forstner J
J Med Microbiol; 2000 Oct; 49(10):875-885. PubMed ID: 11023184
[TBL] [Abstract][Full Text] [Related]
3. Antibody response to Burkholderia cepacia in patients with cystic fibrosis colonized with Burkholderia cepacia and Pseudomonas aeruginosa.
Hendry J; Butler S; Elborn JS; Govan JR; Nelson J; Shale DJ; Webb AK
J Infect; 2000 Mar; 40(2):164-70. PubMed ID: 10841094
[TBL] [Abstract][Full Text] [Related]
4. Burkholderia cepacia: medical, taxonomic and ecological issues.
Govan JR; Hughes JE; Vandamme P
J Med Microbiol; 1996 Dec; 45(6):395-407. PubMed ID: 8958242
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary function, serum markers of inflammation, and IgG antibodies to core lipopolysaccharide of Burkholderia cepacia in adults with cystic fibrosis, following colonization with Burkholderia cepacia.
Hendry J; Nixon L; Dodd M; Elborn JS; Govan J; Shale DJ; Webb AK
Pediatr Pulmonol; 2000 Jan; 29(1):8-10. PubMed ID: 10613780
[TBL] [Abstract][Full Text] [Related]
6. Cystic fibrosis: inflammatory response to infection with Burkholderia cepacia and Pseudomonas aeruginosa.
Hendry J; Elborn JS; Nixon L; Shale DJ; Webb AK
Eur Respir J; 1999 Aug; 14(2):435-8. PubMed ID: 10515426
[TBL] [Abstract][Full Text] [Related]
7. Pseudomonas aeruginosa and Burkholderia cenocepacia infections in patients affected by cystic fibrosis: serum resistance and antibody response.
Savoia D; Deplano C; Zucca M
Immunol Invest; 2008; 37(1):19-27. PubMed ID: 18214797
[TBL] [Abstract][Full Text] [Related]
8. Localization of Burkholderia cepacia complex bacteria in cystic fibrosis lungs and interactions with Pseudomonas aeruginosa in hypoxic mucus.
Schwab U; Abdullah LH; Perlmutt OS; Albert D; Davis CW; Arnold RR; Yankaskas JR; Gilligan P; Neubauer H; Randell SH; Boucher RC
Infect Immun; 2014 Nov; 82(11):4729-45. PubMed ID: 25156735
[TBL] [Abstract][Full Text] [Related]
9. Suppurative mediastinitis secondary to Burkholderia cepacia in a patient with cystic fibrosis.
George RB; Cartier Y; Casson AG; Hernandez P
Can Respir J; 2006; 13(4):215-8. PubMed ID: 16779467
[TBL] [Abstract][Full Text] [Related]
10. Burkholderia cepacia complex: a contraindication to lung transplantation in cystic fibrosis?
LiPuma JJ
Transpl Infect Dis; 2001 Sep; 3(3):149-60. PubMed ID: 11493397
[TBL] [Abstract][Full Text] [Related]
11. Outcome of Burkholderia (Pseudomonas) cepacia colonisation in children with cystic fibrosis following a hospital outbreak.
Whiteford ML; Wilkinson JD; McColl JH; Conlon FM; Michie JR; Evans TJ; Paton JY
Thorax; 1995 Nov; 50(11):1194-8. PubMed ID: 8553277
[TBL] [Abstract][Full Text] [Related]
12. Burkholderia cepacia complex genomovars and pulmonary transplantation outcomes in patients with cystic fibrosis.
De Soyza A; McDowell A; Archer L; Dark JH; Elborn SJ; Mahenthiralingam E; Gould K; Corris PA
Lancet; 2001 Nov; 358(9295):1780-1. PubMed ID: 11734238
[TBL] [Abstract][Full Text] [Related]
13. Burkholderia (Pseudomonas) cepacia and cystic fibrosis: the epidemiology in Belgium.
Revets H; Vandamme P; Van Zeebroeck A; De Boeck K; Struelens MJ; Verhaegen J; Ursi JP; Verschraegen G; Franckx H; Malfroot A; Dab I; Lauwers S
Acta Clin Belg; 1996; 51(4):222-30. PubMed ID: 8858887
[TBL] [Abstract][Full Text] [Related]
14. A comparison of pulmonary exacerbations with single and multiple organisms in patients with cystic fibrosis and chronic Burkholderia cepacia infection.
Mc Manus TE; Moore JE; Crowe M; Dunbar K; Elborn JS
J Infect; 2003 Jan; 46(1):56-9. PubMed ID: 12504610
[TBL] [Abstract][Full Text] [Related]
15. Survival of lung transplant patients with cystic fibrosis harboring panresistant bacteria other than Burkholderia cepacia, compared with patients harboring sensitive bacteria.
Hadjiliadis D; Steele MP; Chaparro C; Singer LG; Waddell TK; Hutcheon MA; Davis RD; Tullis DE; Palmer SM; Keshavjee S
J Heart Lung Transplant; 2007 Aug; 26(8):834-8. PubMed ID: 17692788
[TBL] [Abstract][Full Text] [Related]
16. Distribution and transmission of Pseudomonas aeruginosa and Burkholderia cepacia in a hospital ward.
Döring G; Jansen S; Noll H; Grupp H; Frank F; Botzenhart K; Magdorf K; Wahn U
Pediatr Pulmonol; 1996 Feb; 21(2):90-100. PubMed ID: 8882212
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of Burkholderia species, including members of Burkholderia cepacia complex, among UK cystic and non-cystic fibrosis patients.
Kenna DTD; Lilley D; Coward A; Martin K; Perry C; Pike R; Hill R; Turton JF
J Med Microbiol; 2017 Apr; 66(4):490-501. PubMed ID: 28463663
[TBL] [Abstract][Full Text] [Related]
18. Burkholderia cepacia: current clinical issues, environmental controversies and ethical dilemmas.
Jones AM; Dodd ME; Webb AK
Eur Respir J; 2001 Feb; 17(2):295-301. PubMed ID: 11334134
[TBL] [Abstract][Full Text] [Related]
19. Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis.
Kiska DL; Kerr A; Jones MC; Caracciolo JA; Eskridge B; Jordan M; Miller S; Hughes D; King N; Gilligan PH
J Clin Microbiol; 1996 Apr; 34(4):886-91. PubMed ID: 8815102
[TBL] [Abstract][Full Text] [Related]
20. Pseudomonas aeruginosa and Burkholderia cepacia in cystic fibrosis: genome evolution, interactions and adaptation.
Eberl L; Tümmler B
Int J Med Microbiol; 2004 Sep; 294(2-3):123-31. PubMed ID: 15493822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
